The FDA issues Report Regarding its Oversight Activities
By EsqSocial Corporation 13/05/21
The U.S. Food and Drug Administration (FDA) has faced many operational challenges during the COVID-19 pandemic. Early on, the FDA temporarily postponed routine surveillance facility inspections, conducting mission-critical inspections on a case-by-case basis. Since then, the FDA has leveraged its available tools and implemented innovative approaches to prioritize and resume some routine inspections and has been taking on-going, concrete steps to help stabilize its inspection and assessment...
By: Nexsen Pruet, PLLC